|
| CDKI-73 Basic information |
Product Name: | CDKI-73 | Synonyms: | CDKI-73;Benzenesulfonamide, 3-[[5-fluoro-4-[4-methyl-2-(methylamino)-5-thiazolyl]-2-pyrimidinyl]amino]-;CDKI-73
(CDKI73);CS-2259;asnuciclib;toxicity,Inhibitor,low,AML,Acute,LS 007,myeloid,LS007,leukemia,CLL,Apoptosis,LS-007,endosome,Cyclin dependent kinase,CDKI73,CDKI-73,CDKI 73,inhibit,CDK;3-((5-Fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl)pyrimidin-2-yl)amino)benzenesulfonamide;3-[[5-fluoro-4-[4-methyl-2-(methylamino)-5-thiazolyl]-2-pyrimidinyl]amino]-benzenesulfonamide | CAS: | 1421693-22-2 | MF: | C15H15FN6O2S2 | MW: | 394.45 | EINECS: | | Product Categories: | | Mol File: | 1421693-22-2.mol | |
| CDKI-73 Chemical Properties |
Boiling point | 642.9±65.0 °C(Predicted) | density | 1.524±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:52.0(Max Conc. mg/mL);131.83(Max Conc. mM) | form | Solid | pka | 10.06±0.60(Predicted) | color | Light yellow to yellow |
| CDKI-73 Usage And Synthesis |
Uses | 3-[[5-Fluoro-4-[4-methyl-2-(methylamino)-5-thiazolyl]-2-pyrimidinyl]amino]benzenesulfonamide is a potent CDK inhibitor. A highly efficacious CDK9 inhibitor against acute myeloid leukemia. |
| CDKI-73 Preparation Products And Raw materials |
|